PVI
ITCI

Pura Vida Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Pura Vida Investments’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-168,100
Closed -$3.65M – 115
2018
Q3 		$3.65M Buy
+168,100
New +$3.51M 0.77% 40

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Pura Vida Investments's ITCI Position: Q4 2021 in Review

Pura Vida Investments sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2021, closing a stake of 52,213 shares — an estimated $1.95M sold.

Pura Vida Investments first reported a position in ITCI in Q2 2018 and held it in 5 quarters. The position peaked at $3.85M in Q3 2020. 208 funds tracked by Wall St. Rank hold ITCI as of Q4 2021.

  • Pura Vida Investments reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 52,213 Intra-Cellular Therapies Inc. shares in Q4 2021, an estimated $1.95M.
  • Pura Vida Investments first reported a position in Intra-Cellular Therapies Inc. in Q2 2018 and held it in 5 quarters.
  • Pura Vida Investments's Intra-Cellular Therapies Inc. position peaked at $3.85M in Q3 2020.
  • 208 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.